Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and ...

Enhertu (trastuzumab deruxtecan) has now been approved in China for the treatment of adult patients with unresectable or ...

Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...

Every year, millions of infants and children undergo surgery under general anesthesia in the world. Sevoflurane is a commonly ...

Daiichi Sankyo begins patient dosing in DESTINY-Endometrial02 phase 3 trial of Enhertu in patients with HER2 expressing endometrial cancer: Tokyo Tuesday, December 23, 2025, 10:00 ...

This study in neonatal rats revealed that the common inhaled pediatric anesthetic, sevoflurane, impairs neurogenesis and ...

Every year, millions of infants and children undergo surgery under general anesthesia in the world. Sevoflurane is a commonly used pediatric ...

Health Minister Aaron Motsoaledi reveals that the National Health Laboratory Service is spending up to R18 million monthly on outsourced cancer testing while battling equipment shortages and vacancies ...

Health Minister Aaron Motsoaledi reveals that the National Health Laboratory Service is spending up to R18 million monthly on outsourced cancer testing while battling equipment shortages and 46 ...

Glomus tumours are uncommon, typically benign neoplasms of specialised dermal thermoregulatory structures known as glomus ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...